Ny nomenklatur for fedtleversygdomme

Camilla Dalby Hansen; Katrine Prier Lindvig; Henning Grønbæk; Lise Lotte Gluud; Maja Thiele; Aleksander Krag

doi:10.61409/V12230778

Ny nomenklatur for fedtleversygdomme

Camilla Dalby Hansen
, Katrine Prier Lindvig
, Henning Grønbæk
, Lise Lotte Gluud
, Maja Thiele
, Aleksander Krag

1 Citationer (Scopus)

Abstract

This review investigates that, in 2023, fatty liver disease underwent a name change to "steatotic liver disease" (SLD). SLD now includes metabolic dysfunction-associated steatotic liver disease (MASLD), alcohol-related liver disease (ALD), and metabolic and alcohol-related liver disease (MetALD). The renaming aims to better incorporate alcohol intake and metabolic risk factors into disease classification and to diminish the stigma associated with the previous nomenclature. Early identification of the patient's aetiology is important for the prognosis which can be improved by interventions against the causative risk factors.

Bidragets oversatte titel	New nomenclature for fatty liver disease
Originalsprog	Dansk
Artikelnummer	V12230778
Tidsskrift	Ugeskrift for Laeger
Vol/bind	186
Udgave nummer	19
Sider (fra-til)	1-7
Antal sider	7
ISSN	0041-5782
DOI	https://doi.org/10.61409/V12230778
Status	Udgivet - 6 maj 2024

Emneord

Humans
Terminology as Topic
Risk Factors
Fatty Liver/classification
Fatty Liver, Alcoholic/classification
Alcohol Drinking/adverse effects
Non-alcoholic Fatty Liver Disease/classification
Liver Diseases, Alcoholic/classification

Adgang til dokumentet

10.61409/V12230778

Andre filer og links

Link to publication in Scopus

Citationsformater

@article{e2cc650ec56e48a9b475d526d211d360,

title = "Ny nomenklatur for fedtleversygdomme",

abstract = "This review investigates that, in 2023, fatty liver disease underwent a name change to {"}steatotic liver disease{"} (SLD). SLD now includes metabolic dysfunction-associated steatotic liver disease (MASLD), alcohol-related liver disease (ALD), and metabolic and alcohol-related liver disease (MetALD). The renaming aims to better incorporate alcohol intake and metabolic risk factors into disease classification and to diminish the stigma associated with the previous nomenclature. Early identification of the patient's aetiology is important for the prognosis which can be improved by interventions against the causative risk factors.",

keywords = "Humans, Terminology as Topic, Risk Factors, Fatty Liver/classification, Fatty Liver, Alcoholic/classification, Alcohol Drinking/adverse effects, Non-alcoholic Fatty Liver Disease/classification, Liver Diseases, Alcoholic/classification",

author = "Hansen, \{Camilla Dalby\} and Lindvig, \{Katrine Prier\} and Henning Gr{\o}nb{\ae}k and Gluud, \{Lise Lotte\} and Maja Thiele and Aleksander Krag",

note = "Published under Open Access CC-BY-NC-BD 4.0. https://creativecommons.org/licenses/by-nc-nd/4.0/.",

year = "2024",

month = may,

day = "6",

doi = "10.61409/V12230778",

language = "Dansk",

volume = "186",

pages = "1--7",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske L{\ae}geforening",

number = "19",

}

TY - JOUR

T1 - Ny nomenklatur for fedtleversygdomme

AU - Hansen, Camilla Dalby

AU - Lindvig, Katrine Prier

AU - Grønbæk, Henning

AU - Gluud, Lise Lotte

AU - Thiele, Maja

AU - Krag, Aleksander

N1 - Published under Open Access CC-BY-NC-BD 4.0. https://creativecommons.org/licenses/by-nc-nd/4.0/.

PY - 2024/5/6

Y1 - 2024/5/6

N2 - This review investigates that, in 2023, fatty liver disease underwent a name change to "steatotic liver disease" (SLD). SLD now includes metabolic dysfunction-associated steatotic liver disease (MASLD), alcohol-related liver disease (ALD), and metabolic and alcohol-related liver disease (MetALD). The renaming aims to better incorporate alcohol intake and metabolic risk factors into disease classification and to diminish the stigma associated with the previous nomenclature. Early identification of the patient's aetiology is important for the prognosis which can be improved by interventions against the causative risk factors.

AB - This review investigates that, in 2023, fatty liver disease underwent a name change to "steatotic liver disease" (SLD). SLD now includes metabolic dysfunction-associated steatotic liver disease (MASLD), alcohol-related liver disease (ALD), and metabolic and alcohol-related liver disease (MetALD). The renaming aims to better incorporate alcohol intake and metabolic risk factors into disease classification and to diminish the stigma associated with the previous nomenclature. Early identification of the patient's aetiology is important for the prognosis which can be improved by interventions against the causative risk factors.

KW - Humans

KW - Terminology as Topic

KW - Risk Factors

KW - Fatty Liver/classification

KW - Fatty Liver, Alcoholic/classification

KW - Alcohol Drinking/adverse effects

KW - Non-alcoholic Fatty Liver Disease/classification

KW - Liver Diseases, Alcoholic/classification

UR - https://www.scopus.com/pages/publications/85194850570

U2 - 10.61409/V12230778

DO - 10.61409/V12230778

M3 - Review

C2 - 38808766

SN - 0041-5782

VL - 186

SP - 1

EP - 7

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 19

M1 - V12230778

ER -

Ny nomenklatur for fedtleversygdomme

Abstract

Emneord

Adgang til dokumentet

Andre filer og links

Fingeraftryk

Citationsformater